Essity AB acquires Novioscan, a UMCU spin-off

Essity AB, a hygiene and health company from Sweden, has acquired Novioscan. Novioscan is a venture developing a novel wearable ultrasound technology, aimed at continence control. The technology was partly based on research at the University Medical Center Utrecht (UMCU).

Read the international press release from Essity below.

Essity acquires smart ultrasound technology for incontinence care

Hygiene and health company Essity is strengthening its offering in incontinence products through the acquisition of the Dutch company Novioscan. The company develops a wearable ultrasound technology that monitors the bladder and enables continence control. The purchase price is approximately SEK 70m (EUR 6.5m) on a debt-free basis.

The SENS-U innovation is a wearable ultrasound sensor that measures the level in the bladder. It sends a discrete notification that allows the user to empty their bladder in time. A version of SENS-U for children is already available in the market and an adult version is under development.

The SENS-U technology is an innovative solution that will strengthen Essity’s offering in incontinence care and give consumers an opportunity to live a healthier and more active life,” says Ulrika Kolsrud, President Health and Medical Solutions of Essity.

Novioscan was founded in 2014 in Nijmegen, the Netherlands, and has ten employees, all of whom will remain in the company. Essity is the leading global player in incontinence products with the TENA brand. Incontinence affects 4-8% of the world’s adult population. Essity works to break barriers and the stigma associated with incontinence to improve well-being and help people live life to the fullest.

For further information, please contact:
Per Lorentz, Vice President Corporate Communications, +46 8 788 52 51, | Johan Karlsson, Vice President Investor Relations, +46 8 788 51 30,


Essity is a leading global hygiene and health company. We are dedicated to improving well-being through our products and services. Sales are conducted in approximately 150 countries under the leading global brands TENA and Tork, and other strong brands, such as JOBST, Leukoplast, Libero, Libresse, Lotus, Nosotras, Saba, Tempo, Vinda and Zewa. Essity has about 46,000 employees. Net sales in 2019 amounted to approximately SEK 129bn (EUR 12.2bn). The company’s headquarters is located in Stockholm, Sweden, and Essity is listed on Nasdaq Stockholm. Essity breaks barriers to well-being and contributes to a healthy, sustainable and circular society. More information at

Message: by Essity.